SCHEMBL5146545

SCHEMBL5146545

CCCc1nc2c(N)nc3ccc(-c4cccc(NC(C)=O)c4)cc3c2s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 9/20 0.58
TLR7 Q9NYK1 7/20 0.58
MAP4K4 O95819 4/20 0.53
LIMK1 P53667 2/20 0.49
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
PKM P14618 1/20 0.44
KMT2A Q03164 1/20 0.44
LIMK2 P53671 1/20 0.44
NQO2 P16083 1/20 0.42
GAA P10253 1/20 0.42
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
FYN P06241 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5144714 0.93 TLR8 (0.54) TLR8TLR7MAP4K4LIMK1KDM4E
SCHEMBL5144797 0.91 TLR8 (0.61) TLR8TLR7MAP4K4LIMK1RAB9A
SCHEMBL5144711 0.85 TLR8 (0.58) TLR8TLR7SMN1; SMN2MEN1ALDH1A1
SCHEMBL5147713 0.83 TLR8 (0.55) TLR8TLR7LIMK1
SCHEMBL5144807 0.81 TLR8 (0.64) TLR8TLR7MAP4K4LIMK1
SCHEMBL5146430 0.80 TLR8 (0.65) TLR8TLR7
SCHEMBL5146527 0.80 TLR8 (0.61) TLR8TLR7LIMK1
SCHEMBL5146442 0.79 TLR8 (0.69) TLR8TLR7
SCHEMBL5144741 0.78 TLR8 (0.67) TLR8TLR7LIMK1
SCHEMBL3988438 0.77 TLR8 (0.54) TLR8TLR7LIMK1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY 2007-11-08 US disclosed
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY 2007-11-08 US disclosed
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY 2007-11-08 US disclosed
WO-2006093514-A2 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES IL2, TSLP, IFNG TLR8 86/4885TLR7 39/4885MAP4K4 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.